UCSF

ZINC03932831

Substance Information

In ZINC since Heavy atoms Benign functionality
October 20th, 2005 37 No

CAS Number: 164656-23-9

Other Names:

(1S,3aS,3bS,5aR,9aR,11aS)-N-[2,5-bis(trifluoromethyl)phenyl]-9a,11a-dimethyl-7-oxo-1,2,3,3a,3b,4,5,5a,6,9b,10,11-dodecahydroindeno[5,4-f]quinoline-1-carboxamide

(1S,3aS,3bS,5aR,9aR,9bS,11aS)-N-[2,5-bis(trifluoromethyl)phenyl]-9a,11a-dimethyl-7-oxo-1,2,3,3a,3b,4,5,5a,6,9b,10,11-dodecahydroindeno[5,4-f]quinoline-1-carboxamide

(5.alpha.,17.beta.)-N-{2,5 bis(trifluoromethyl)phenyl}-3-oxo-4-azaandrost-1-ene-17-carboxamide

(5alpha,17beta)-N-(2,5-Bis(trifluoromethyl)phenyl)-3-oxo-4-azaandrost-1-ene-17-carboxamide

(5alpha,17beta)-N-(2,5-Bis(trifluoromethyl)phenyl)-3-oxo-4-azaandrost-1-ene-17-carboxamide; 1H-Indeno(5,4-f)quinoline-7-carboxamide, N-(2,5-bis(trifluoromethyl)phenyl)-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-4a,6a-dimethyl-2-oxo-, (4aR,4bS,6aS

(5alpha,17beta)-N-(2,5-bis(trifluoromethyl)phenyl)-3-oxo-4-azaandrost-1-ene-17-carboxamide; alpha,alpha,alpha,alpha',alpha',alpha'-hexafluoro-3-oxo-4-aza-5alpha-androst-1-ene-17beta-carboxy-2',5'-xylidide

ster-

steride

164656-23-9

164656-23-9; Avodart (TN); D03820; Dutasteride (JAN/USAN/INN)

1H-Indeno(5,4-f)quinoline-7-carboxamide, N-(2,5-bis(trifluoromethyl)phenyl)-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-4a,6a-dimethyl-2-oxo-, (4aR,4bS,6aS,7S,9aS,9bS,11aR)-

3,4-Dimethyl-benzene-1,2-diamine

AC1L49EM

AC1OCF98

alpha,alpha,alpha,alpha',alpha',alpha'-Hexafluoro-3-oxo-4-aza-5alpha-androst-1-ene-17beta-carboxy-2',5'-xylidide

Avidart

Avodart

Avodart (TN)

Avodart, Dutasteride

Avodart

Avolve

BAN

Bio-0167

C27H30F6N2O2

CHEBI:132773

CHEMBL1200969

CHEMBL283245

CID152945

CID6918296

CID9914880

D03820

DAP000044

DB01126

Duagen

Duprost

Dutagen

Dutas

Dutasteride (BAN

Dutasteride (FDA

Dutasteride (JAN/USAN/INN)

Dutasteride [USAN]

FDA

FT-0080365

GG 745

GG-745

GG-745; GI-198745

GI 198745

GI-198745

GI-198745X

INN

LS-173584

MolPort-003-666-660

MolPort-003-847-041

N-[2,5-bis(trifluoromethyl)phenyl]-3-oxo-4-aza-5alpha-androst-1-ene-17beta-carboxamide

NSC740477

S1202_Selleck

UNII-O0J6XJN02I

USAN)

ZINC03932831

Download: MOL2 SDF SMILES Flexibase

Physical Representations

Type pH range xlogP Des A‑Pol Apolar desolvation (kcal/mol) Des Pol Polar desolvation (kcal/mol) H Don H-bond donors H Acc H-bond acceptors Chg Net charge tPSA (Ų) MWT Molecular weight (g/mol) RB Rotatable bonds DL
Ref Reference (pH 7) 6.23 3.14 -13.5 2 4 0 58 528.537 4

Vendor Notes

Note Type Comments Provided By
mechanism 5 alpha reductase inhibitor IBScreen Bioactives
Therapy 5-alpha-reductase inhibitor SMDC Pharmakon
ALOGPS_SOLUBILITY 9.08e-04 g/l DrugBank-approved
biological_use Under investigation for treatment of benign prostatic hyperplasia IBScreen Bioactives
PUBCHEM_PATENT_ID US6054455; WO1999036030A2; WO1999059583A1; WO2000037107A2; WO2000038665A2; WO2000038718A2; WO2000038719A1; WO2000038730A2; WO2000038786A2; WO2000066072A1; WO2000066080A1; WO2000066081A1 IBM Patent Data

Activity (Go SEA)

Clustered Target Annotations
Code Description Organism Class Affinity (nM) LE (kcal/mol/atom) Type
S5A1-1-E Steroid 5-alpha-reductase 1 (cluster #1 Of 2), Eukaryotic Eukaryotes 2 0.33 Binding ≤ 10μM
S5A1-1-E Steroid 5-alpha-reductase 1 (cluster #1 Of 2), Eukaryotic Eukaryotes 6 0.31 Binding ≤ 10μM
S5A2-2-E Steroid 5-alpha-reductase 2 (cluster #2 Of 2), Eukaryotic Eukaryotes 0 0.00 Binding ≤ 10μM
S5A2-2-E Steroid 5-alpha-reductase 2 (cluster #2 Of 2), Eukaryotic Eukaryotes 1 0.34 Binding ≤ 10μM
ChEMBL Target Annotations
Uniprot Swissprot Description Affinity (nM) LE (kcal/mol/atom) Type
S5A1_HUMAN P18405 Steroid 5-alpha-reductase 1, Human 5.8 0.31 Binding ≤ 1μM
S5A2_HUMAN P31213 Steroid 5-alpha-reductase 2, Human 0.1 0.38 Binding ≤ 1μM
S5A1_HUMAN P18405 Steroid 5-alpha-reductase 1, Human 5.8 0.31 Binding ≤ 10μM
S5A2_HUMAN P31213 Steroid 5-alpha-reductase 2, Human 0.1 0.38 Binding ≤ 10μM

Reactome Annotations from Targets (via Uniprot)

Description Species
Androgen biosynthesis

Analogs ( Draw Identity 99% 90% 80% 70% )